Multicenter evaluation of the VITEK MS matrix-assisted laser desorption/ionization-time of flight mass spectrometry system for identification of bacteria, including Brucella, and yeasts.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 22 01 2021
accepted: 30 03 2021
pubmed: 11 4 2021
medline: 27 11 2021
entrez: 10 4 2021
Statut: ppublish

Résumé

The use of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry has proven to be rapid and accurate for the majority of clinical isolates. Some gaps remain concerning rare, emerging, or highly pathogenic species, showing the need to continuously expand the databases. In this multicenter study, we evaluated the accuracy of the VITEK MS v3.2 database in identifying 1172 unique isolates compared to identification by DNA sequence analysis. A total of 93.6% of the isolates were identified to species or group/complex level. A remaining 5.2% of the isolates were identified to the genus level. Forty tests gave a result of no identification (0.9%) and 12 tests (0.3%) gave a discordant identification compared to the reference identification. VITEK MS is also the first MALDI-TOF MS system that is able to delineate the four members of the Acinetobacter baumannii complex at species level without any specific protocol or special analysis method. These findings demonstrate that the VITEK MS v3.2 database is highly accurate for the identification of bacteria and fungi encountered in the clinical laboratory as well as emerging species like Candida auris and the highly pathogenic Brucella species.

Identifiants

pubmed: 33837878
doi: 10.1007/s10096-021-04242-1
pii: 10.1007/s10096-021-04242-1
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1909-1917

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Branda JA, Rychert J, Burnham CA et al (2014) Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis 78(2):129–131. https://doi.org/10.1016/j.diagmicrobio.2013.08.013
doi: 10.1016/j.diagmicrobio.2013.08.013 pubmed: 24321357
Garner O, Mochon A, Branda J et al (2014) Multi-centre evaluation of mass spectrometric identification of anaerobic bacteria using the VITEK® MS system. Clin Microbiol Infect 20(4):335–339. https://doi.org/10.1111/1469-0691.12317
doi: 10.1111/1469-0691.12317 pubmed: 23927597
Manji R, Bythrow M, Branda JA et al (2014) Multi-center evaluation of the VITEK® MS system for mass spectrometric identification of non-Enterobacteriaceae Gram-negative bacilli. Eur J Clin Microbiol Infect Dis 33(3):337–346. https://doi.org/10.1007/s10096-013-1961-2
doi: 10.1007/s10096-013-1961-2 pubmed: 24019163
Richter SS, Sercia L, Branda JA et al (2013) Identification of Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using the VITEK MS system. Eur J Clin Microbiol Infect Dis 32(12):1571–1578. https://doi.org/10.1007/s10096-013-1912-y
doi: 10.1007/s10096-013-1912-y pubmed: 23818163
Rychert J, Burnham CA, Bythrow M et al (2013) Multicenter evaluation of the Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Gram-positive aerobic bacteria. J Clin Microbiol 51(7):2225–2231. https://doi.org/10.1128/JCM.00682-13
doi: 10.1128/JCM.00682-13 pubmed: 23658261 pmcid: 3697712
Westblade LF, Jennemann R, Branda JA et al (2013) Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol 51(7):2267–2272. https://doi.org/10.1128/JCM.00680-13
doi: 10.1128/JCM.00680-13 pubmed: 23658267 pmcid: 3697678
Body BA, Beard MA, Slechta ES et al (2018) Evaluation of the Vitek MS v3.0 matrix-assisted laser desorption ionization-time of flight mass spectrometry system for identification of Mycobacterium and Nocardia species. J Clin Microbiol 56(6):e00237–e00218 Published 2018 May 25. 10.1128/JCM.00237-18
doi: 10.1128/JCM.00237-18
Rychert J, Slechta ES, Barker AP et al (2018) Multicenter evaluation of the Vitek MS v3.0 system for the identification of filamentous fungi. J Clin Microbiol 56(2):e01353–e01317 Published 2018 Jan 24. 10.1128/JCM.01353-17
doi: 10.1128/JCM.01353-17
Welker M, Van Belkum A, Girard V, Charrier JP, Pincus D (2019) An update on the routine application of MALDI-TOF MS in clinical microbiology. Expert Rev Proteomics 16(8):695–710. https://doi.org/10.1080/14789450.2019.1645603
doi: 10.1080/14789450.2019.1645603 pubmed: 31315000
Janda JM, Lopez DL (2017) Mini review: new pathogen profiles: Elizabethkingia anophelis. Diagn Microbiol Infect Dis 88(2):201–205. https://doi.org/10.1016/j.diagmicrobio.2017.03.007
doi: 10.1016/j.diagmicrobio.2017.03.007 pubmed: 28342565
Spivak ES, Hanson KE (2018) Candida auris: an emerging fungal pathogen. J Clin Microbiol 56(2):e01588–e01517 Published 2018 Jan 24. 10.1128/JCM.01588-17
doi: 10.1128/JCM.01588-17
Rodríguez-Medina N, Barrios-Camacho H, Duran-Bedolla J, Garza-Ramos U (2019) Klebsiella variicola: an emerging pathogen in humans. Emerg Microbes Infect 8(1):973–988. https://doi.org/10.1080/22221751.2019.1634981
doi: 10.1080/22221751.2019.1634981 pubmed: 31259664 pmcid: 6609320
Ramos R, Caceres DH, Perez M et al (2018) Emerging multidrug-resistant Candida duobushaemulonii infections in Panama Hospitals: importance of laboratory surveillance and accurate identification. J Clin Microbiol 56(7):e00371–e00318. Published 2018 Jun 25. https://doi.org/10.1128/JCM.00371-18
doi: 10.1128/JCM.00371-18 pubmed: 29695521 pmcid: 6018349
Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA (2005) Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 4(3):625–632. https://doi.org/10.1128/EC.4.3.625-632.2005
doi: 10.1128/EC.4.3.625-632.2005 pubmed: 15755924 pmcid: 1087803
Kidd SE, Goeman E, Meis JF, Slavin MA, Verweij PE (2015) Multi-triazole-resistant Aspergillus fumigatus infections in Australia. Mycoses. 58(6):350–355. https://doi.org/10.1111/myc.12324
doi: 10.1111/myc.12324 pubmed: 25885568
Arastehfar A, Khodavaisy S, Daneshnia F et al (2019) Molecular identification, genotypic diversity, antifungal susceptibility, and clinical outcomes of infections caused by clinically underrated yeasts, Candida orthopsilosis, and Candida metapsilosis: an Iranian multicenter study (2014-2019). Front Cell Infect Microbiol 9:264. Published 2019 Jul 30. https://doi.org/10.3389/fcimb.2019.00264
doi: 10.3389/fcimb.2019.00264 pubmed: 31417877 pmcid: 6682699
Chusri S, Chongsuvivatwong V, Rivera JI et al (2014) Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob Agents Chemother 58(7):4172–4179. https://doi.org/10.1128/AAC.02992-14
doi: 10.1128/AAC.02992-14 pubmed: 24820079 pmcid: 4068534
Mesureur J, Ranaldi S, Monnin V, Girard V, Arend S, Welker M et al (2016) A simple and safe protocol for preparing Brucella samples for matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis. J Clin Microbiol 54:449–452. https://doi.org/10.1128/JCM.02730-15
doi: 10.1128/JCM.02730-15 pubmed: 26582837 pmcid: 4733191
Porte L, García P, Braun S et al (2017) Head-to-head comparison of Microflex LT and Vitek MS systems for routine identification of microorganisms by MALDI-TOF mass spectrometry in Chile. PLoS One 12(5):e0177929. Published 2017 May 18. https://doi.org/10.1371/journal.pone.0177929
doi: 10.1371/journal.pone.0177929 pubmed: 28542393 pmcid: 5436840
Wattal C, Oberoi JK, Goel N, Raveendran R, Khanna S (2017) Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory. Eur J Clin Microbiol Infect Dis 36(5):807–812. https://doi.org/10.1007/s10096-016-2864-9
doi: 10.1007/s10096-016-2864-9 pubmed: 27987046
Girard V, Mailler S, Chetry M et al (2016) Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry. Mycoses. 59(8):535–538. https://doi.org/10.1111/myc.12519
doi: 10.1111/myc.12519 pubmed: 27292939
Kwon YJ, Shin JH, Byun SA et al (2019) Candida auris clinical isolates from South Korea: identification, antifungal susceptibility, and genotyping. J Clin Microbiol 57(4):e01624–e01618. Published 2019 Mar 28. https://doi.org/10.1128/JCM.01624-18
doi: 10.1128/JCM.01624-18 pubmed: 30728190 pmcid: 6440790
Vijayakumar S, Biswas I, Veeraraghavan B (2019) Accurate identification of clinically important Acinetobacter spp.: an update. Future Sci OA 5(6):FSO395. Published 2019 Jun 27. https://doi.org/10.2144/fsoa-2018-0127
doi: 10.2144/fsoa-2018-0127 pubmed: 31285840 pmcid: 6609899
Sali M, De Maio F, Tarantino M et al (2018) Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry. PLoS One 13(6):e0197864. Published 2018 Jun 5. https://doi.org/10.1371/journal.pone.0197864
doi: 10.1371/journal.pone.0197864 pubmed: 29870530 pmcid: 5988274
Poonawala H, Marrs Conner T, Peaper DR (2018) Closing the brief case: misidentification of Brucella melitensis as Ochrobactrum anthropi by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). J Clin Microbiol 56(6):e00918–e00917. Published 2018 May 25. https://doi.org/10.1128/JCM.00918-17
doi: 10.1128/JCM.00918-17 pubmed: 29802239 pmcid: 5971527

Auteurs

Victoria Girard (V)

R&D Microbiology, bioMérieux sa, La Balme les Grottes, France. victoria.girard@biomerieux.com.

Valérie Monnin (V)

R&D Microbiology, bioMérieux sa, La Balme les Grottes, France.

Delphine Giraud (D)

R&D Microbiology, bioMérieux sa, La Balme les Grottes, France.

Sophie Polsinelli (S)

R&D Microbiology, bioMérieux sa, La Balme les Grottes, France.

Marion Caillé (M)

R&D Microbiology, bioMérieux sa, La Balme les Grottes, France.
MSD, Clermont-Ferrand, France.

Gary W Procop (GW)

Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Marion Tuohy (M)

Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Deborah Wilson (D)

Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.

Sandra S Richter (SS)

Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
Medical Affairs, bioMérieux, Inc., Durham, NC, USA.

Katalin Kiss (K)

ATCC, Manassas, VA, USA.

Kimberly Clem (K)

ATCC, Manassas, VA, USA.

Nicholas Tolli (N)

ATCC, Manassas, VA, USA.

Laurence Bridon (L)

Clinical Affairs, bioMérieux sa, Marcy L'Étoile, France.

Constance Bradford (C)

Clinical Affairs, bioMérieux, Inc., St. Louis, MO, USA.

Sara Blamey (S)

Clinical Affairs, bioMérieux, Inc., St. Louis, MO, USA.

Jay Li (J)

R&D US Data Science, bioMérieux, Inc., Durham, NC, USA.

David H Pincus (DH)

R&D Microbiology, bioMérieux, Inc., St. Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH